Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis

BACKGROUND AND PURPOSE: The considerable clinical effect of natalizumab in patients with relapsing-remitting multiple sclerosis might be explained by its possible beneficial effect on axonal functioning. In this longitudinal study, the effect of natalizumab on absolute concentrations of total N-acet...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:AJNR Am J Neuroradiol
Auteurs principaux: Wiebenga, O.T., Klauser, A.M., Schoonheim, M.M., Nagtegaal, G.J.A., Steenwijk, M.D., van Rossum, J.A., Polman, C.H., Barkhof, F., Pouwels, P.J.W., Geurts, J.J.G.
Format: Artigo
Langue:Inglês
Publié: American Society of Neuroradiology 2015
Sujets:
Brain
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8013024/
https://ncbi.nlm.nih.gov/pubmed/25742985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A4252
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires